5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Prophylactic sildenafil citrate improves select aspects of sexual function in men treated with radiotherapy for prostate cancer.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We studied adjuvant daily sildenafil citrate during and after radiotherapy for prostate cancer for erectile function preservation.

          Related collections

          Author and article information

          Journal
          J. Urol.
          The Journal of urology
          Elsevier BV
          1527-3792
          0022-5347
          Sep 2014
          : 192
          : 3
          Affiliations
          [1 ] Departments of Radiation Oncology and Urology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: zelefskm@mskcc.org.
          [2 ] Department of Radiation Oncology, Continuum Cancer Center of New York, New York, New York.
          [3 ] Departments of Radiation Oncology and Urology, Memorial Sloan Kettering Cancer Center, New York, New York.
          [4 ] Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
          [5 ] Departments of Radiation Oncology and Urology, Mt. Sinai Medical Center, New York, New York.
          Article
          S0022-5347(14)00355-3
          10.1016/j.juro.2014.02.097
          24603102
          e6592bfc-08b6-433d-ac08-34c70d1afe25
          History

          erectile dysfunction,prostate,prostatic neoplasms,radiotherapy,sildenafil

          Comments

          Comment on this article